Methods and systems for providing gender specific pharmaceuticals

A system of gender specific pharmaceuticals, the system comprising:

• a first package comprising a pharmaceutical for use by a male, wherein the pharmaceutical comprises a central nervous system depressant, the first package comprising:
• at least one male dosage having a first dosage amount;
• a first insert positioned in the first package, the first insert including a recommended male dosage and a recommended female dosage that is different than the male dosage;
• and
• a first label coupled to the first package, wherein at least one of the provided first label and first package includes a male gender specifier;
• and
• a second package comprising a pharmaceutical for use by a female, wherein the pharmaceutical comprises a central nervous system depressant, the second package comprising:
• at least one female dosage having a second dosage amount that is smaller than the first dosage amount;
• a second insert positioned in the second package, the second insert including a recommended male dosage and a recommended female dosage that is different than the male dosage;
• and
• a second label coupled to the second package, wherein at least one of the provided second label and second package includes a female gender specifier, wherein the female gender specifier is different than the male gender specifier.

A method for providing gender specific pharmaceuticals, the method comprising:

• providing a first package comprising a pharmaceutical for use by a male, wherein the pharmaceutical comprises a central nervous system depressant, the first package comprising:
• at least one male dosage having a first dosage amount;
• and
• a first label coupled to the first package, the label including a male gender specifier;
• and
• providing a second package comprising a pharmaceutical for use by a female, wherein the pharmaceutical comprises a central nervous system depressant, the second package comprising:
• at least one female dosage having a second dosage amount that is different than the first dosage amount;
• and
• a second label coupled to the second package, the second label including a female gender specifier, wherein the female gender specifier is different than the male gender specifier.

A system of gender specific pharmaceuticals, the system comprising:

• a first package comprising a pharmaceutical for use by a male, wherein the pharmaceutical comprises a central nervous system depressant, the first package comprising:
• at least one male dosage having a first dosage amount;
• and
• a first label coupled to the first package, the label including a male gender specifier;
• and
• a second package comprising a pharmaceutical for use by a female, wherein the pharmaceutical comprises a central nervous system depressant, the second package comprising:
• at least one female dosage having a second dosage amount that is different than the first dosage amount;
• and
• a second label coupled to the second package, the second label including a female gender specifier, wherein the female gender specifier is different than the male gender specifier.